MedTrace Logo

SUV Max as Predictor of Outcome in Cervical Cancer

NCT01262144 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2010-12-17

No results posted yet for this study

Summary

Cervical Cancer is staged clinically, not surgically. Patients in whom an extensive disease is identified are not usually eligible for surgery. PET-CT is used to support staging. However, some patients received surgery after staging and subsequently require radio/chemotherapy due to findings on operation.

This study will attempt to find a correlation between SUV-Max on PET-CT and subsequent outcomes i.e. need for adjuvant therapy.

Conditions

Interventions

RADIATION

Radiotherapy

Radiotherapy for cervical cancer

Sponsors & Collaborators

  • Rambam Health Care Campus

    lead OTHER

Principal Investigators

  • Amnon Amit, MD · Rambam Health Care Campus

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31

Countries

  • Israel

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01262144 on ClinicalTrials.gov